Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 09, 2019

SELL
$0.97 - $1.42 $19,497 - $28,542
-20,100 Closed
0 $0
Q4 2018

Feb 08, 2019

SELL
$1.0 - $6.12 $12,000 - $73,440
-12,000 Reduced 37.38%
20,100 $22,000
Q2 2018

Aug 10, 2018

BUY
$8.91 - $14.54 $89,100 - $145,400
10,000 Added 45.25%
32,100 $343,000
Q2 2017

Aug 11, 2017

BUY
N/A
22,100
22,100 $201,000

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $56.6M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.